CVX™ Viral RNA Extraction Kit has been validated for RNA isolation from SARS-CoV-19 clinical samples. 60 positive samples and 20 negative samples were collected from nasopharyngeal exudates and RNA isolation was made in parallel using it and a comparator kit. After RNA isolation qPCR was done using the protocol described by Corman VM et al, 2020, also known as “Charité protocol”. An internal mRNA co-isolated along with viral RNA was used as a positive control.

CE-IVD Certified for usage in in-vitro Diagnostics (License No.: 7817-PS).

Includes for 500 rxn:
– 500 MiniSpin Columns
– 1,000 Collection tubes (2 mL)
– 1 vial Carrier RNA (lyophilized)
– 300 mL BLQ Buffer
– 165 mL WB1 Buffer
– 100 mL WB2 Buffer
– 50 mL RNase-free Water

The purified viral RNA is suitable for use in RT-PCR and qRT-PCR and can be used for:

• Viral Load Monitoring.
• Viral Detection.
• Viral Genotyping.

• Specifically validated for SARS-CoV-19 by Spanish Institution Instituto de Salud Carlos III (ISCIII)
• CE-IVD Certified for usage in in-vitro Diagnostics (License No.: 7817-PS).

Qiagen® and QIAcube® are registred Trademarks of QIAGEN Group.

• Shipped in: Ambient Temperature. Carrier RNA solution in Gel Pack/Dry Ice.
• Storage: All components can be stored at Room Temperature, except Carrier RNA solution at –20 °C. If any kit reagent forms a precipitate, warm at 55–65 °C until the precipitate dissolves, and allow cooling to room temperature before use.

This product is developed, designed and tested for both research (RUO) and in vitro diagnosis (IVD) purposes. The product has not been tested for use in drug development, nor is suitable for administration to humans or animals. Please refer to www.canvaxbiotech.com for Material Safety Data Sheet (MSDS) of the product.  Please refer to www.canvaxbiotech.com for Material Safety Data Sheet of the product.